Concepedia

Baiteng Zhao

BZ

Statistics

Publications

18

Citations

1.1K

H-Index

16

Active since

2001

Affiliations

Seagen (United States)(Current)

University of Alabama at Birmingham

Memorial Sloan Kettering Cancer Center

Moffitt Cancer Center

The University of Texas MD Anderson Cancer Center

Baiteng Zhao is an author at Seagen (United States) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2001–2017

18

Publications

18

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Eytan M. Stein, Roland B. Walter, Harry P. Erba et al. · Blood · 2017 · 177 citations · Full text

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma

Nizar M. Tannir, Andres Forero‐Torres, Radhakrishnan Ramchandren et al. · Investigational New Drugs · 2014 · 126 citations

, , +5

cDNA microarray reveals altered cytoskeletal gene expression in space‐flown leukemic T lymphocytes (Jurkat)

Marian L. Lewis, Luis A. Cubano, Baiteng Zhao et al. · The FASEB Journal · 2001 · 115 citations

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

Anne M. Traynor, Maureen R. Hewitt, Glenn Liu et al. · Cancer Chemotherapy and Pharmacology · 2010 · 86 citations · Full text

, , +7

Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays

Baiteng Zhao, Robert A. Bowden, Salomon Stavchansky et al. · American Journal of Physiology-Cell Physiology · 2001 · 86 citations

, , +16

1–5 of 18